PD-L1 expression in medulloblastoma: an evaluation by subgroup

Area of Science:

• Pediatric Oncology
• Immunology
• Neuro-oncology

Background:

• Medulloblastoma (MB) is the most common malignant pediatric brain tumor.
• Evaluating PD-L1 expression and immune-mediated resistance markers is crucial for understanding MB.
• This study investigates PD-L1 in human MB samples.

Purpose of the Study:

• To assess PD-L1 expression levels in human medulloblastoma.
• To identify factors influencing PD-L1 expression, including molecular subgroup and microenvironment.
• To explore the role of PD-L1 in immune escape in pediatric brain tumors.

Main Methods:

• Human MB tumor samples were analyzed for PD-L1 and immune cell markers.
• Expression analysis was correlated with molecular subgroup.
• Functional analysis of PD-L1 expression was performed under IFN-γ, radiation, and MYC overexpression conditions.

Main Results:

• Overall PD-L1 levels in human MB were low, but some cases showed focal expression with increased immune infiltrates.
• Sonic hedgehog (SHH) MB exhibited the highest PD-L1 expression.
• IFN-γ robustly stimulated PD-L1 expression in all cell lines, while radiation showed variable effects.

Conclusions:

• Medulloblastoma expresses low PD-L1, contributing to immune evasion.
• T_H1 cytokine stimulation is a potent inducer of PD-L1 expression in vitro.
• An inflamed tumor microenvironment is likely necessary for PD-1 pathway activation in MB.